Article Details
Retrieved on: 2021-05-20 00:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
High-cost therapies such as the newly available monoclonal antibodies are playing their part in the escalating cost of severe childhood asthma.
Article found on: www.dovepress.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here